Ir.genedx.com

Investor Relations GeneDx

At GeneDx, we believe that everyone deserves personalized, targeted medical care—and that it all begins with a genetic diagnosis. Fueled by one of the world’s largest rare disease data sets, our industry-leading exome and genome tests translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies.

Actived: 1 days ago

URL: https://ir.genedx.com/investor-relations/

Sema4 Announces the Completion of the GeneDx Acquisition and …

WebAcquisition creates an AI-driven advanced health intelligence company, now leveraging one of the largest genomic testing platforms in the U.S. Katherine Stueland, former President …

Category:  Health Go Health

GeneDx Reports Fourth Quarter and Full Year 2022 Financial …

WebCombined Company revenue for the full year of 2022 was $234.7 million, compared to $212.2 million in 2021, representing an increase of 10%. Total Company …

Category:  Health Go Health

Sema4GeneDx To Provide Whole Genome Sequencing and …

WebThe largest study of its kind in North America, GUARDIAN is expected to improve population health by identifying more than 250 preventable and treatable conditions, many of which …

Category:  Health Go Health

Sema4 Launches New Genomic Testing and Digital Tools for Use …

WebDemos will be available at the ASCO Annual Meeting in Chicago. Stamford, CT — May 30, 2019 — Sema4, a patient-centered health intelligence company, today announced the …

Category:  Health Go Health

GeneDx to Report First Quarter 2024 Financial Results on Monday, …

WebSTAMFORD, Conn., April 04, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today …

Category:  Health Go Health

GeneDx Announces Data Demonstrating that Whole Exome and …

WebSTAMFORD, Conn., Aug. 21, 2023 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that …

Category:  Health Go Health

GeneDx Announces Progress on GUARDIAN Study and Promise of …

WebGenome Sequencing and Interpretation Services Progressing Quickly for 1,000 Newborns Enrolled in Study to Date; On Track to Support up to 100,000 Study Participants in Next …

Category:  Health Go Health

Eric Schadt Management GeneDx

WebEric Schadt, Ph.D., is founder and CEO of Sema4, a patient-centered health intelligence company built on the idea that more information, deeper analysis, and increased. …

Category:  Health Go Health

GeneDx Makes Significant Industry-Wide Contributions to New …

WebCompany submitted nearly one quarter of all candidate gene submissions to GeneMatcher in 2022 and collaborated on 63 publications involving new disease-gene associations or …

Category:  Health Go Health

PacBio and GeneDx Launch Research Collaboration with the …

WebStudy is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms . MENLO PARK, Calif. and STAMFORD, Conn., Aug. 07, 2023 (GLOBE …

Category:  Health Go Health

Sema4 Appoints Renowned Oncologist William Oh, M.D. as Chief …

WebSTAMFORD, CT — January 14, 2021 — Sema4, a patient-centered health intelligence company, today announced the appointment of William K. Oh, M.D., to the newly …

Category:  Health Go Health

NorthShore and Sema4 Launch System-Wide Genomics Program …

Web(Evanston, IL and Stamford, CT) April 19, 2021 — NorthShore University HealthSystem (NorthShore) and Sema4, a patient-centered health intelligence company, …

Category:  Health Go Health

GeneDx Rare Disease Data Demonstrates Utility in Drug Candidate

WebResearch published in Nature Genetics underscores the role of genetic insights in the drug discovery and development process. STAMFORD, Conn., Feb. 16, 2023 (GLOBE …

Category:  Health Go Health

GeneDx Announces Partnership with Komodo Health to Expand …

WebThe Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine …

Category:  Medicine Go Health

News Releases GeneDx

WebGeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024. Read More. March 14, 2024.

Category:  Health Go Health

GeneDx Appoints Devin K. Schaffer, J.D., M.B.A, as General Counsel …

WebGeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that Devin K. Schaffer has been appointed …

Category:  Health Go Health

GeneDx and Prognos Health Announce Strategic Partnership to …

WebPartnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patients …

Category:  Health Go Health

Investor Presentation J.P. Morgan Healthcare Conference

WebCorporate Snapshot 1 Headcount as of December 31, 2021 2Sema4's guidance is subject to certain assumptions, risks and uncertainties.See Disclaimer on slide 2. 3 Annualized …

Category:  Health Go Health